Klein R Z, Haddow J E, Faix J D, Brown R S, Hermos R J, Pulkkinen A, Mitchell M L
Department of Maternal and Child Health, Dartmouth Medical School, Hanover, NH 03756.
Clin Endocrinol (Oxf). 1991 Jul;35(1):41-6. doi: 10.1111/j.1365-2265.1991.tb03494.x.
The present study was designed to determine the current prevalence of gestational hypothyroidism, since maternal thyroxine deficiency is associated with poor obstetric outcomes and mental retardation in the surviving offspring.
TSH concentrations were measured in the sera of women at 15-18 weeks of gestation. Those sera with TSH concentrations above 6 mU/l and the two sera closest in order with TSH concentrations below 6 mU/l were further analysed for T4, FT4, TBG, and antithyroid antibodies. Study criteria for hypothyroidism were sera with elevated concentrations of TSH plus both a free T4 concentration and a total T4 concentration and/or T4/TBG ratio more than two standard deviations below the mean for the control pregnant women.
The sera were from 2000 consecutive women in Maine being tested for alpha-fetoprotein concentration at 15-18 weeks of gestation.
TSH concentrations above 6 mU/l were found in the sera of 49 women, 2.5% of the pregnant women. Six women with elevated TSH concentrations (range 6.9-54 mU/l) had both a FT4 concentration and a T4/TBG ratio and/or a T4 concentration more than two standard deviations below the respective control means, meeting the study criteria for thyroid deficiency, and thus giving a prevalence of 0.3%. The remaining 43 women with elevated TSH concentrations were classified as having compensated thyroid disease although some may have been hypothyroid. Fifty-eight per cent of women with TSH concentrations above 6 mU/l and 90% of the women with elevated TSH concentrations and at least one thyroxine index more than two standard deviations below the control means had positive titres of antithyroid antibodies as opposed to 11% of the controls.
Although it is not known what severity of maternal thyroid deficiency is necessary to cause fetal brain damage, the present data indicate a sufficiently high prevalence of thyroid dysfunction to demand investigation of the mental development of the offspring of women with thyroid dysfunction and of the effect of replacement therapy.
鉴于母亲甲状腺素缺乏与不良产科结局以及存活后代的智力发育迟缓相关,本研究旨在确定当前妊娠期甲状腺功能减退症的患病率。
在妊娠15 - 18周的女性血清中测量促甲状腺激素(TSH)浓度。对TSH浓度高于6 mU/l的血清以及TSH浓度低于6 mU/l且顺序最接近的两份血清进一步分析甲状腺素(T4)、游离甲状腺素(FT4)、甲状腺素结合球蛋白(TBG)和抗甲状腺抗体。甲状腺功能减退症的研究标准为TSH浓度升高且游离T4浓度、总T4浓度和/或T4/TBG比值比对照孕妇的均值低两个标准差以上的血清。
血清来自缅因州2000名连续妊娠15 - 18周时接受甲胎蛋白浓度检测的女性。
在49名女性(占孕妇的2.5%)的血清中发现TSH浓度高于6 mU/l。6名TSH浓度升高(范围为6.9 - 54 mU/l)的女性,其FT4浓度、T4/TBG比值和/或T4浓度比各自对照均值低两个标准差以上,符合甲状腺功能减退的研究标准,患病率为0.3%。其余43名TSH浓度升高的女性被归类为患有代偿性甲状腺疾病,尽管其中一些可能是甲状腺功能减退。TSH浓度高于6 mU/l的女性中有58%,TSH浓度升高且至少一项甲状腺素指标比对照均值低两个标准差以上的女性中有90%抗甲状腺抗体滴度呈阳性,而对照组为11%。
虽然尚不清楚母亲甲状腺功能减退的何种严重程度会导致胎儿脑损伤,但目前的数据表明甲状腺功能障碍的患病率足够高,需要对甲状腺功能障碍女性后代的智力发育以及替代疗法的效果进行研究。